NeoGenomics Reaches Analyst Target Price
October 26, 2018 at 07:52 AM EDT
In recent trading, shares of NeoGenomics Inc (NEO) have crossed above the average analyst 12-month target price of $14.86, changing hands for $14.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..